Join the 200th Anniversary Celebration

Original Article

Effects of Regular Exercise on Blood Pressure and Left Ventricular Hypertrophy in African-American Men with Severe Hypertension

Peter F. Kokkinos, Ph.D., Puneet Narayan, M.D., John A. Colleran, D.O., Andreas Pittaras, M.D., Aldo Notargiacomo, B.S., Domenic Reda, M.S., and Vasilios Papademetriou, M.D.

N Engl J Med 1995; 333:1462-1467November 30, 1995

Abstract

Background

The prevalence of hypertension and its cardiovascular complications is higher in African Americans than in whites. Interventions to control blood pressure in this population are particularly important. Regular exercise lowers blood pressure in patients with mild-to-moderate hypertension, but its effects in patients with severe hypertension have not been studied. We examined the effects of moderately intense exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension.

Methods

We randomly assigned 46 men 35 to 76 years of age to exercise plus antihypertensive medication (23 men) or antihypertensive medication alone (23 men). A total of 18 men in the exercise group completed 16 weeks of exercise, and 14 completed 32 weeks of exercise, which was performed three times per week at 60 to 80 percent of the maximal heart rate.

Results

After 16 weeks, mean (±SD) diastolic blood pressure had decreased from 88±7 to 83±8 mm Hg in the patients who exercised, whereas it had increased slightly, from 88±6 to 90±7 mm Hg, in those who did not exercise (P = 0.002). Diastolic blood pressure remained significantly lower after 32 weeks of exercise, even with substantial reductions in the dose of antihypertensive medication. In addition, the thickness of the interventricular septum (P = 0.03), the left ventricular mass (P = 0.02), and the left-ventricular mass index (P = 0.04) had decreased significantly after 16 weeks in the patients who exercised, whereas there was no significant change in the nonexercisers.

Conclusions

Regular exercise reduced blood pressure and left ventricular hypertrophy in African-American men with severe hypertension.

Media in This Article

Table 1Base-Line Characteristics of the Exercise and No-Exercise Groups.
Table 2Clinical Characteristics of the Patients in the Exercise and No-Exercise Groups at Base Line and after 16 Weeks.
Article

Chronic essential hypertension is a major risk factor for cardiovascular disease.1-3 Morbidity and mortality from cardiovascular causes increase curvilinearly as blood pressure rises, with no evidence of a threshold of risk.4

Antihypertensive therapy has reduced the incidence of congestive heart failure, renal failure, and stroke4-6 but has failed to produce the expected reductions in coronary morbidity and mortality.4-7 Various explanations have been proposed, including adverse effects of some antihypertensive agents on carbohydrate and lipid metabolism8,9 and poor compliance with medication regimens. Even when drug therapy is effective, side effects and cost considerations lead to poor compliance and poorly controlled hypertension. Thus, nonpharmacologic therapy as an adjunct treatment or alternative to drug therapy is desirable.

Aerobic exercise of moderate intensity reduces blood pressure in patients with mild-to-moderate essential hypertension10-16 and is now recommended to lower blood pressure in such patients.3,17,18 Exercise of lower intensity reduces the risk of injury and cardiac complications19,20 and makes exercise feasible for most patients. These factors, along with the low cost, absence of side effects, and additional cardiovascular benefits,21 make the use of exercise to lower blood pressure appealing.

Patients with systolic blood pressure of at least 180 mm Hg and diastolic blood pressure of at least 110 mm Hg (those with severe hypertension)17 have a risk of coronary heart disease that is about five times the risk in those with systolic blood pressure of 120 mm Hg or less and diastolic blood pressure of 80 mm Hg or less.2 Most patients with severe hypertension have left ventricular hypertrophy22 and require a combination of antihypertensive medications, which increases the chance of side effects and poor compliance.

Information about the effects of exercise on blood pressure in such patients, and more specifically in African Americans, is lacking. Since the prevalence of hypertension and its cardiovascular sequelae is higher in African Americans than in whites,23 interventions to control blood pressure optimally in this population are particularly important.

We undertook this study to assess the effects of regular aerobic exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension.

Methods

We recruited 46 African-American men with essential hypertension, 35 to 76 years of age, for this study. All the patients had sedentary lifestyles, as defined by the absence of a regular exercise program during the preceding six months. Inclusion criteria were an age over 21 years and a history of essential hypertension, with untreated diastolic blood pressure of at least 110 mm Hg or systolic blood pressure of at least 180 mm Hg. Patients were excluded from the study if they had a history of congestive heart failure; stroke; evidence of coronary heart disease, based on stress tests or stress thallium scintigraphy; insulin-dependent diabetes mellitus; or alcoholism, drug abuse, or psychiatric disease.

Each patient signed a consent form, approved by the local institutional review board, and was randomly assigned to drug therapy plus exercise (23 patients) or drug therapy alone (23 patients).

Antihypertensive Drug Therapy

Antihypertensive medication was prescribed for all the patients to reduce diastolic blood pressure to 95 mm Hg or less, or 10 mm Hg below pretreatment levels. Blood pressure was measured every two weeks and medication was adjusted, until the target blood pressure was achieved. Treatment was initiated with 2.5 mg of indapamide (Lozol) per day. If this was not effective in controlling blood pressure, 120 mg of sustained-release verapamil (Verelan) per day was added. Verapamil was increased as necessary to a maximal dose of 480 mg per day, depending on the patient's needs and ability to tolerate the drug. If the target blood pressure was not achieved with this combination, enalapril (Vasotec) was added. The dose of enalapril ranged from 2.5 to 40 mg per day.

Patients were evaluated on three occasions to ensure that their blood pressure was persistently controlled. Target blood-pressure control was achieved in all patients.

Patients were advised and frequently reminded not to alter their dietary habits during the study. Patients in the no-exercise group were also advised to maintain the same level of physical activity. Patients were seen at least monthly in our clinic.

Peak Oxygen Uptake and Blood Pressure

Peak oxygen uptake was assessed in the exercise group at base line and after 16 weeks of training. Each patient breathed through a mouthpiece with a two-way valve while running on a treadmill at a speed that elicited 75 percent of the age-predicted maximal heart rate, at a grade of 0 percent. The grade was increased from 0 to 4 percent at the beginning of the fourth minute, and by 2 percent every minute after the end of the fifth minute. Oxygen uptake was recorded every 30 seconds (Medical Graphics Cardiopulmonary Exercise System 2001). Peak oxygen uptake was considered to have been reached when the patient became too tired to continue.

Exercise blood pressure, heart rate, and the product of rate times pressure were also measured at maximal workloads attained at base line and after 16 weeks of training. The maximal workload attained at base line was used as the submaximal workload in evaluations of the same variables after training.

Resting and Exercise Blood Pressure

Resting blood pressure was measured with the patient sitting comfortably for 5 to 10 minutes and the cuff arm supported at the heart level.24 Measurements were made by a Hawksley random-zero sphygmomanometer. All readings were taken between 8 and 10 a.m. To ensure that readings were made under similar conditions, blood pressure in the exercise group was recorded during the first four exercise sessions but before the patients began to exercise. Four readings were obtained per session, for a total of 16 readings. The mean of these 16 readings is reported as the base-line resting blood pressure. The procedure was repeated during the last four exercise sessions to measure the post-training resting blood pressure. Blood pressure for the control group was recorded during the first and last four visits attended.

Echocardiography

M-mode and two-dimensional echocardiograms were recorded with patients in the left lateral decubitus position, by a technician unaware of the study assignments. M-mode tracings that were guided two-dimensionally were recorded on light-sensitive paper at 50 mm per second (Hewlett–Packard Sonos 1000, with a 2.5-MHz transducer), from the short parasternal axis at the chordal level between the free edges of the mitral leaflets at the tips of the papillary muscles. To decrease variability, five cardiac cycles were read and the values averaged.25 Only tracings with optimal visualization of left ventricular interfaces were used. In our echocardiographic laboratory, the range of variability of observations by a single reader is 0 mm to 1.5 mm for the dimensions of the left ventricular cavity, and 0 mm to 0.5 mm for wall thickness. Tracings were read at the end of the study independently by two cardiologists, who were unaware of the study groups and the date of echocardiographic assessment. When there was a disagreement between the two readers, the final value was settled by consensus.

Left ventricular diastolic dimensions (LVDD), systolic dimensions (LVSD), interventricular septal thickness (IVS), and posterior-wall thickness (PW) were measured in all patients according to the guidelines of the American Society of Echocardiography.26 Left ventricular mass was calculated with the use of the anatomically validated formula

left ventricular mass = 1.04 [(IVS + LVDD + PW)3 - (LVDD)3] - 13.6 g.

Left ventricular mass was divided by body-surface area to obtain the left-ventricular-mass index. Left ventricular fractional shortening was calculated with the use of the standard formula

fractional shortening (%) = [(LVDD - LVSD) / LVDD] × 100.

Exercise Program

Patients in the exercise group participated in an aerobic-exercise program that consisted of two phases, each 16 weeks long. Exercise training for both phases consisted of stationary cycling on Windracer exercise bicycles (Randal Sports Medicine Equipment, Kirkland, Wash.) three times per week. Exercise sessions started with a five-minute warm-up period (stretching and slow cycling) before the prescribed aerobic exercise and ended with an appropriate cooling-off period. Patients exercised for a mean (±SD) of 44±9 minutes, at approximately 74 percent of the predicted maximal heart rate.

Phase 1

Patients initially cycled for 5 to 10 minutes at 60 percent of their maximal heart rates. The duration of exercise increased progressively and on an individual basis as patients tolerated longer exercise sessions. The duration and intensity of the actual exercise phase were maintained for 20 to 60 minutes at 60 to 80 percent of the predicted maximal heart rate. Heart rate was measured continuously with a portable heart-rate monitor (Pacer). Blood pressure was monitored periodically during each workout to ensure that it was within safe limits (systolic blood pressure, <220 mm Hg; diastolic blood pressure, <110 mm Hg). The workload was adjusted to maintain the target heart rate and blood pressure within the prescribed limits throughout the exercise session.

Phase 2

This phase consisted of continued exercise and follow-up for an additional 16 weeks. If the diastolic blood pressure fell below 90 mm Hg and at least 5 mm Hg below the base-line value in any patient, the dose of antihypertensive medication was reduced. The reduction generally started with enalapril, in a stepwise fashion and in the reverse of the order in which the medications had been initiated, and occurred at weeks 20, 24, and 28 of the training program. During the period of medication reduction, blood pressure was measured weekly and during routine monthly follow-up visits to the clinic.

Statistical Analysis

The t-test for independent groups was used in the following analyses: base-line comparisons of the randomized groups, comparisons of changes from base line to weeks 16 and 32 between the two groups, and base-line comparisons of patients for whom 16-week echocardiographic data were available with patients for whom they were not. Multiple-regression analysis was used to examine treatment-related changes in echocardiographic measurements after adjustment for base-line differences. The exercise metabolic data, which were collected only on the exercise group, were recorded at base line and at 16 weeks; the one-sample t-test was used to compare values at the two time points. All tests of significance were two-sided, and differences were considered statistically significant when P<0.05. SAS version 6.08 was used for all analyses.

Results

The clinical characteristics of the patients are shown in Table 1Table 1Base-Line Characteristics of the Exercise and No-Exercise Groups.. Comparisons of the exercise and no-exercise groups revealed no base-line differences in any variables examined except the thickness of the left ventricular posterior wall (13.0±1.4 vs. 11.9±1.8 mm; P = 0.02), the systolic dimension (31.2±4.9 vs. 34.7±5.3 mm; P = 0.04), the ejection fraction (71±10 percent vs. 64±11 percent; P = 0.03), and fractional shortening (37.4±6.7 percent vs. 31.8±5.3 percent; P<0.003). There was a trend toward a larger left-ventricular-mass index in patients in the exercise group (162.2±39.7 vs. 147.1±28.7; P = 0.14).

Eighteen of the 23 patients assigned to the exercise group completed phase 1. One patient dropped out early in the study because of an interim diagnosis of deep venous thrombosis, one was withdrawn for not complying with the medication regimen, and three were withdrawn for not complying with the exercise program. In the no-exercise group, three patients were withdrawn for not taking their medication.

After phase 1, 14 of the 18 patients in the exercise group continued with phase 2. Three patients could not attend clinic exercise sessions because of work schedules, and one moved out of town. Two patients from the no-exercise group did not want to continue in the study. Medication was successfully reduced in 10 of the 14 patients in the exercise group. The average reductions in the dose of medication for the group were 24 percent, 38 percent, and 37 percent for indapamide, verapamil, and enalapril, respectively. The numbers of exercise-group patients whose medication was reduced or discontinued was four and two, respectively, for indapamide, eight and three for verapamil, and two and one for enalapril. None of the patients in the no-exercise group met the criteria for a reduction of medication. The percentage of patients whose medication was reduced was significantly higher (by Fisher's exact test) in the exercise group than in the no-exercise group (P<0.001).

Changes from base line to week 16 in body weight, body-surface area, and body-mass index did not differ between the two randomized groups (Table 2Table 2Clinical Characteristics of the Patients in the Exercise and No-Exercise Groups at Base Line and after 16 Weeks.). Table 3Table 3Exercise Data for the Exercise Group at Base Line and after 16 Weeks of Exercise Training. shows exercise data for the 14 patients in the exercise group who completed the metabolic exercise test at 16 weeks. Peak oxygen uptake increased significantly. The maximal heart rate was unchanged, but the heart rate at the submaximal workload was significantly lower at 16 weeks than at base line. Exercise systolic and diastolic blood pressure and the rate–pressure product at maximal and submaximal workloads were also significantly lower at 16 weeks (Table 3).

The decrease in diastolic blood pressure at 16 weeks in the patients randomly assigned to the exercise group was significantly different from the slight increase in those assigned to the no-exercise group. Differences in the reductions in systolic blood pressure and resting heart rate between the exercise group and the no-exercise group approached significance. Among the patients who completed 32 weeks of study, the change in diastolic blood pressure from base line was significantly greater in the exercise group (Table 4Table 4Resting Blood Pressure and Heart Rate at Base Line and after 16 and 32 Weeks.).

The echocardiographic data are shown in Table 5Table 5Echocardiographic Data on 15 Patients in the Exercise Group and 17 Patients in the No-Exercise Group.. For 32 of the 46 patients (15 in the exercise group and 17 in the no-exercise group), complete data were available at 16 weeks. There were no base-line differences between patients for whom echocardiographic data were available at 16 weeks and those for whom they were not, except for trends toward lower values for base-line posterior-wall thickness (P = 0.10) and higher values for body-mass index (P = 0.13) in the patients with echocardiographic data available. Eleven exercising and 10 nonexercising patients had left ventricular hypertrophy, defined as a left-ventricular-mass index greater than 134 g per square meter of body-surface area. At 16 weeks, the exercise group had significantly larger reductions from base line in interventricular septal thickness, left ventricular mass, and left-ventricular-mass index than the no-exercise group. Changes in left ventricular systolic and diastolic dimensions, ejection fraction, and fractional shortening were not significantly different.

Discussion

Reduction in Blood Pressure with Exercise

We observed a significant reduction in diastolic blood pressure and regression of left ventricular hypertrophy in African-American men with severe hypertension after 16 weeks of moderately intense aerobic exercise. In addition, exercising for more than 16 weeks resulted in a further fall in blood pressure, permitting a substantial reduction in antihypertensive medication.

Systolic blood pressure also decreased, by 7 mm Hg and 6 mm Hg after 16 and 32 weeks of exercise, respectively. Although these changes are clinically important,2 neither reached statistical significance.

Severe hypertension is difficult to manage and often requires multiple antihypertensive medications for effective control. Such complex treatments burden patients financially and increase the possibility of adverse effects and poor compliance. Our results show that severe hypertension can be managed more effectively with a combination of drug therapy and regular, moderately intense exercise. Most important, medications necessary to control blood pressure without exercise can be curtailed substantially as patients continue exercising.

Blood pressure at the maximal exercise level, blood pressure at a submaximal workload, and the rate–pressure product — an indicator of myocardial oxygen consumption — were also lower after 16 weeks of regular exercise. The lower rate–pressure product observed at maximal workload was entirely due to lower systolic blood pressure, since values for maximal heart rate before and after exercising were similar. The rate–pressure product at submaximal workload was 18 percent lower than at base line.

The general consensus is that regular aerobic exercise reduces blood pressure significantly in patients with mild-to-moderate essential hypertension.10-15 Our results show that the effectiveness of moderately intense exercise extends to patients with severe hypertension. Moderately intense exercise carries a lower risk of musculoskeletal injuries and acute cardiovascular events than does intense exercise.19,20 Patients are also more likely to initiate and continue a lower-intensity exercise program than a higher-intensity one.

The underlying mechanism or mechanisms responsible for the exercise-induced reduction in blood pressure remain unclear. Recent evidence shows that insulin resistance and hyperinsulinemia may contribute to the pathogenesis of hypertension.27,28 Insulin levels at a 16-week follow-up visit were 33 percent lower than those at base line in the exercise group (22.2±18 vs. 14.8±9 μU per milliliter [133±108 vs. 89±54 pmol per liter]) and 9 percent lower than base-line levels in the no-exercise group (26.7±23 vs. 24.2±21 μU per milliliter [160±138 vs. 145±126 pmol per liter]). However, differences in the changes in insulin levels between the two groups were not statistically significant.

Regression of Left Ventricular Hypertrophy

Left ventricular hypertrophy is an independent risk factor for cardiovascular disease.22,29 Morbid events from cardiovascular causes, including sudden cardiac death, are three times as frequent in patients with left ventricular hypertrophy.22,29

Regression of left ventricular hypertrophy after a reduction in blood pressure has been reported with most antihypertensive medications.30-32 However, the effects of prolonged exercise on ventricular structure and function are not clear. The rigorous exercise endured by athletes can provoke cardiac enlargement. The “athlete's heart,” as it is commonly called, is exercise-specific. Purely aerobic exercises induce enlargement of the left ventricular cavity, with no changes in left-ventricular-wall thickness.33 In contrast, combined isotonic and isometric exercise (e.g., weight training and rowing) may lead to substantial hypertrophy of the left ventricular wall.34 Nevertheless, exercise-induced left ventricular hypertrophy is considered a normal physiologic adaptation to the particularly rigorous training of athletes. It is not associated with diastolic dysfunction, arrhythmias, or an adverse prognosis, as is hypertension-induced left ventricular hypertrophy,35,36 and it regresses quickly with detraining.37

In contrast to athletes, our patients exercised at a relatively low intensity and duration. After 16 weeks of such training, we observed a significant reduction in the thickness of the interventricular septum and 12 percent reductions in left ventricular mass and left-ventricular-mass index. The reduction in left ventricular mass was similar to the reduction of 8 to 15 percent in overall left ventricular mass that has been reported in drug studies.31 There were no changes in any echocardiographic measurements in the no-exercise group. Our findings and those of studies of highly trained athletes33,34 suggest that the intensity and duration of exercise may have an important effect on left ventricular structure.

The mechanisms involved in the regression of left ventricular hypertrophy in the patients in our exercise group are not readily apparent. It is likely that the reduction in blood pressure has played a part. In general, most antihypertensive regimens that lower blood pressure induce various degrees of reduction in left ventricular mass without any drug-specific effects.31,32 Other factors, however, such as levels of angiotensin II and catecholamines, may be involved.38 Prolonged physical activity decreases plasma catecholamines in some hypertensive patients.10-12

In conclusion, we found that African-American men with severe hypertension and left ventricular hypertrophy benefit from a combined regimen of regular, moderately intense aerobic exercise and antihypertensive drug therapy. The antihypertensive effects of exercise substantially reduced the amount of medication required to control blood pressure.

Supported in part by grants from Lederle Laboratories and Rolland Medical Equipment.

Source Information

From the Cardiology Division, Veterans Affairs Medical Center, Washington, D.C. (P.F.K., P.N., J.A.C., A.P., A.N., V.P.); the Cardiology Division, Georgetown University Medical Center, Washington, D.C. (P.F.K., P.N., J.A.C., V.P.); and the Cooperative Studies Program, Veterans Affairs Hospital, Hines, Ill. (D.R.).

Address reprint requests to Dr. Papademetriou at the Cardiology Division, Veterans Affairs Medical Center, 50 Irving St., NW, Washington, DC 20422.

References

References

  1. 1

    MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774
    CrossRef | Web of Science | Medline

  2. 2

    Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: U.S. population data. Arch Intern Med 1993;153:598-615
    CrossRef | Web of Science | Medline

  3. 3

    National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med 1993;153:186-208
    CrossRef | Web of Science | Medline

  4. 4

    Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med 1992;152:56-64
    CrossRef | Web of Science | Medline

  5. 5

    Effects of treatment on morbidity in hypertensionII. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-1152
    CrossRef | Web of Science

  6. 6

    Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2571
    CrossRef | Web of Science

  7. 7

    Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982;248:1465-1477
    CrossRef | Web of Science

  8. 8

    Ames RP. Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative drug therapies. Am J Cardiol 1983;51:632-638
    CrossRef | Web of Science | Medline

  9. 9

    Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-873
    Full Text | Web of Science | Medline

  10. 10

    Urata H, Tanabe Y, Kiyonaga A, et al. Antihypertensive and volume-depleting effects of mild exercise on essential hypertension. Hypertension 1987;9:245-252
    Web of Science | Medline

  11. 11

    Duncan JJ, Farr JE, Upton SJ, Hagan RD, Oglesby ME, Blair SN. The effects of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA 1985;254:2609-2613
    CrossRef | Web of Science | Medline

  12. 12

    Hagberg JM, Montain SJ, Martin WH III, Ehsani AA. Effects of exercise training in 60- to 69-year-old persons with essential hypertension. Am J Cardiol 1989;64:348-353
    CrossRef | Web of Science | Medline

  13. 13

    American College of Sports Medicine. Physical activity, physical fitness, and hypertension. Med Sci Sports Exerc 1993;25:i-x
    Medline

  14. 14

    Hagberg JM. Exercise, fitness, and hypertension. In: Bouchard C, Shephard RJ, Stephens T, Sutton JR, McPherson BD, eds. Exercise, fitness, and health: a consensus of current knowledge. Champaign, Ill.: Human Kinetics Books, 1990:455-66.

  15. 15

    Kokkinos PF, Narayan P, Papademetriou V. Exercise training and hypertension in adult patients. Cardiol Elderly 1994;2:433-438
    Web of Science

  16. 16

    Baglivo HP, Fabregues G, Burrieza H, Esper RC, Talarico M, Esper RJ. Effect of moderate physical training on left ventricular mass in mild hypertensive persons. Hypertension 1990;15:Suppl I:I-153

  17. 17

    The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183
    CrossRef | Web of Science | Medline

  18. 18

    Physical exercise in the management of hypertension: a consensus statement by the World Hypertension LeagueJ Hypertens 1991;9:283-287
    CrossRef | Web of Science | Medline

  19. 19

    Powell KE, Kohl HW, Caspersen CJ, Blair SN. An epidemiologic perspective on the causes of running injuries. Physician Sports Med 1986;14:100-114

  20. 20

    Friedewald VE Jr, Spence DW. Sudden cardiac death associated with exercise: the risk-benefit issue. Am J Cardiol 1990;66:183-188
    CrossRef | Web of Science | Medline

  21. 21

    Fletcher GF, Blair SN, Blumenthal J, et al. Benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:340-344
    Web of Science | Medline

  22. 22

    Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566
    Full Text | Web of Science | Medline

  23. 23

    Hypertension prevalence and the status of awareness, treatment, and control in the United States: final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension 1985;7:457-468
    Web of Science | Medline

  24. 24

    Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the Steering Committee, American Heart Association. Circulation 1988;77:502A-514A
    Web of Science

  25. 25

    Devereux RB, Liebson PR, Horan MJ. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987;9:Suppl II:II-97

  26. 26

    Sahn DJ, DeMaria A, Kisslo J, Weymen A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083
    Web of Science | Medline

  27. 27

    Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357
    Full Text | Web of Science | Medline

  28. 28

    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
    CrossRef | Web of Science | Medline

  29. 29

    Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-178
    Web of Science | Medline

  30. 30

    Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med 1990;322:1350-1356
    Full Text | Web of Science | Medline

  31. 31

    Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95-110
    Web of Science | Medline

  32. 32

    Liebson PR. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Am J Hypertens 1990;3:512-517[Erratum, J Hypertens 1990;9:following Table of Contents.]
    Web of Science | Medline

  33. 33

    Maron BJ. Structural features in the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986;7:190-203
    CrossRef | Web of Science | Medline

  34. 34

    Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301
    Full Text | Web of Science | Medline

  35. 35

    Granger CB, Karimeddini MK, Smith VE, Shapiro HR, Katz AM, Riba Al. Rapid ventricular filling in left ventricular hypertrophy. I. Physiologic hypertrophy. J Am Coll Cardiol 1985;5:862-868
    CrossRef | Web of Science | Medline

  36. 36

    McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787-792
    Full Text | Web of Science | Medline

  37. 37

    Martin WH III, Coyle EF, Bloomfield SA, Esani AA. Effects of physical deconditioning after intense endurance training on left ventricular dimensions and stroke volume. J Am Coll Cardiol 1986;7:982-989
    CrossRef | Web of Science | Medline

  38. 38

    Devereux RB. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. Vol. 1. New York: Raven Press, 1990:359-77.

Citing Articles (71)

Citing Articles

  1. 1

    Luciana V. Rossoni, Raphael A.F. Oliveira, Rene R. Caffaro, Maria Miana, David Sanz-Rosa, Márcia K. Koike, Sandra L. Do Amaral, Lisete C. Michelini, Vicente Lahera, Victoria Cachofeiro. (2011) Cardiac benefits of exercise training in aging spontaneously hypertensive rats. Journal of Hypertension 29:12, 2349-2358
    CrossRef

  2. 2

    Peter Kokkinos, Helen Sheriff, Raya Kheirbek. (2011) Physical Inactivity and Mortality Risk. Cardiology Research and Practice 2011, 1-10
    CrossRef

  3. 3

    Julian Segura, Alejandro Sierra, Luis M. Ruilope. (2010) Detection and Treatment of Resistant Hypertension. Current Hypertension Reports 12:5, 325-330
    CrossRef

  4. 4

    Andreas N. Kavazis. (2009) Exercise Preconditioning of the Myocardium. Sports Medicine 39:11, 923-935
    CrossRef

  5. 5

    Jennifer Dorosz. (2009) Updates in Cardiac Rehabilitation. Physical Medicine and Rehabilitation Clinics of North America 20:4, 719-736
    CrossRef

  6. 6

    Klaus-Michael Braumann. (2009) Bewegungstherapie bei Hypertonie. Sport- und Präventivmedizin 39:2, 18-21
    CrossRef

  7. 7

    Melicia C. Whitt-Glover, Shiriki K. Kumanyika. (2009) Systematic Review of Interventions to Increase Physical Activity and Physical Fitness in African-Americans. American Journal of Health Promotion 23:6, S33-S56
    CrossRef

  8. 8

    Kurt Boman, Eva Gerdts, Kristian Wachtell, Björn Dahlöf, Markku S. Nieminen, Mona Olofsson, Vasilios Papademetriou, Richard B. Devereux. (2009) Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. European Journal of Cardiovascular Prevention & Rehabilitation 16:2, 242-248
    CrossRef

  9. 9

    Donk-Kyum You, So-Young Lee, Tae-Yong Lee, Eun-Hee Lee. (2009) Concordance of Hypertension in Husband and Wife Living in a Rural Area. Journal of the Korea Academia-Industrial cooperation Society 10:3, 634-641
    CrossRef

  10. 10

    James E. Sharman, Michael Stowasser. (2009) Australian Association for Exercise and Sports Science Position Statement on Exercise and Hypertension. Journal of Science and Medicine in Sport 12:2, 252-257
    CrossRef

  11. 11

    Gordana Petrovic-Oggiano, Vlasta Damjanov, Vesna Vucic, Jasmina Debeljak-Martacic, Mirjana Pavlovic, Marija Glibetic. (2009) Effects of three types of physical activity on reduction of metabolic parameters involved in cardiovascular risk. Archives of Biological Sciences 61:3, 367-374
    CrossRef

  12. 12

    Deborah Minor, Marion Wofford, Sharon B. Wyatt. (2008) Does socioeconomic status affect blood pressure goal achievement?. Current Hypertension Reports 10:5, 390-397
    CrossRef

  13. 13

    BIRINDER SINGH BOBBY CHEEMA. (2008) Review article: Tackling the survival issue in end-stage renal disease: Time to get physical on haemodialysis. Nephrology 13:7, 560-569
    CrossRef

  14. 14

    Barbara Strasser, Paul Haber, Christoph Strehblow, Edmund Cauza. (2008) The benefit of strength training on arterial blood pressure in patients with type 2 diabetes mellitus measured with ambulatory 24-hour blood pressure systems. Wiener Medizinische Wochenschrift 158:13-14, 379-384
    CrossRef

  15. 15

    Franco Giada, Alessandro Biffi, Piergiuseppe Agostoni, Alberto Anedda, Romualdo Belardinelli, Roberto Carlon, Bruno Carù, Luigi DʼAndrea, Pietro Delise, Antonino De Francesco, Francesco Fattirolli, Riccardo Guglielmi, Umberto Guiducci, Antonio Pelliccia, Maria Penco, Francesco Perticone, Gaetano Thiene, Margherita Vona, Paolo Zeppilli. (2008) Exercise prescription for the prevention and treatment of cardiovascular diseases: part II. Journal of Cardiovascular Medicine 9:6, 641-652
    CrossRef

  16. 16

    P. Palatini, P. Visentin, F. Dorigatti, C. Guarnieri, M. Santonastaso, S. Cozzio, F. Pegoraro, A. Bortolazzi, O. Vriz, L. Mos, . (2008) Regular physical activity prevents development of left ventricular hypertrophy in hypertension. European Heart Journal 30:2, 225-232
    CrossRef

  17. 17

    Deborah S. Minor, Marion R. Wofford, Daniel W. Jones. (2008) Racial and ethnic differences in hypertension. Current Atherosclerosis Reports 10:2, 121-127
    CrossRef

  18. 18

    J.M. Casillas, V. Gremeaux, S. Damak, A. Feki, D. Pérennou. (2007) Exercise training for patients with cardiovascular disease. Annales de Réadaptation et de Médecine Physique 50:6, 403-418
    CrossRef

  19. 19

    J.-M. Casillas, V. Gremeaux, S. Damak, A. Feki, D. Pérennou. (2007) Entraînement à l'effort au cours des pathologies cardiovasculaires. Annales de Réadaptation et de Médecine Physique 50:6, 386-402
    CrossRef

  20. 20

    Alessandra Rocha Pinheiro, Ana Rosa Cunha, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. (2007) Beneficial effects of physical exercise on hypertension and cardiovascular adverse remodeling of diet-induced obese rats. Nutrition, Metabolism and Cardiovascular Diseases 17:5, 365-375
    CrossRef

  21. 21

    Maria Penco, Renata Petroni, Francesca Pastori, Simona Fratini, Silvio Romano. (2006) Should sports activity be encouraged or contraindicated in hypertensive subjects?. Journal of Cardiovascular Medicine 7:4, 288-295
    CrossRef

  22. 22

    B. K. Pedersen, B. Saltin. (2006) Evidence for prescribing exercise as therapy in chronic disease. Scandinavian Journal of Medicine and Science in Sports 16:S1, 3-63
    CrossRef

  23. 23

    W.J. Elliott. (2006) Effect of Exercise on Blood Pressure in Older Persons: A Randomized Controlled Trial. Yearbook of Cardiology 2006, 53-55
    CrossRef

  24. 24

    Hussam Abuissa, Avinash Khanna, John Spertus. (2005) Low rates of exercise in patients with metabolic syndrome after an acute coronary syndrome. Clinical Cardiology 28:11, 530-533
    CrossRef

  25. 25

    Adrian S. Fairey, Kerry S. Courneya, Catherine J. Field, Gordon J. Bell, Lee W. Jones, Blair St. Martin, John R. Mackey. (2005) Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: A randomized controlled trial. Brain, Behavior, and Immunity 19:5, 381-388
    CrossRef

  26. 26

    B M Y Cheung, J L F Lo, D Y T Fong, M Y Chan, S H T Wong, V C W Wong, K S L Lam, C P Lau, J P E Karlberg. (2005) Randomised controlled trial of qigong in the treatment of mild essential hypertension. Journal of Human Hypertension 19:9, 697-704
    CrossRef

  27. 27

    Edmund Cauza, Ursula Hanusch-Enserer, Barbara Strasser, Bernhard Ludvik, Sylvia Metz-Schimmerl, Giovanni Pacini, Oswald Wagner, Petra Georg, Rudolf Prager, Karam Kostner, Attila Dunky, Paul Haber. (2005) The Relative Benefits of Endurance and Strength Training on the Metabolic Factors and Muscle Function of People With Type 2 Diabetes Mellitus. Archives of Physical Medicine and Rehabilitation 86:8, 1527-1533
    CrossRef

  28. 28

    A. Alevizos, J. Lentzas, S. Kokkoris, A. Mariolis, P. Korantzopoulos. (2005) Physical activity and stroke risk. International Journal of Clinical Practice 59:8, 922-930
    CrossRef

  29. 29

    Norberto Andaluz, Mario Zuccarello. (2005) Place of Drug Therapy in the Treatment of Carotid Stenosis. CNS Drugs 19:7, 597-622
    CrossRef

  30. 30

    Satish Kenchaiah, Jagat Narula, Ramachandran S. Vasan. (2004) Risk factors for heart failure. Medical Clinics of North America 88:5, 1145-1172
    CrossRef

  31. 31

    Matthew Weir. (2004) Healthy Diet and Blood Pressure. The Journal of Clinical Hypertension 6:7, 381-382
    CrossRef

  32. 32

    Linda S. Pescatello, Barry A. Franklin, Robert Fagard, William B. Farquhar, George A. Kelley, Chester A. Ray. (2004) Exercise and Hypertension. Medicine & Science in Sports & Exercise 36:3, 533-553
    CrossRef

  33. 33

    Simon L Bacon, Andrew Sherwood, Alan Hinderliter, James A Blumenthal. (2004) Effects of Exercise, Diet and Weight Loss on High Blood Pressure. Sports Medicine 34:5, 307-316
    CrossRef

  34. 34

    Jonathan M McGavock, Neil D Eves, Sandra Mandic, Nicole M Glenn, H Arthur Quinney, Mark J Haykowsky. (2004) The Role of Exercise in the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes Mellitus. Sports Medicine 34:1, 27-48
    CrossRef

  35. 35

    David T. Lowenthal, Kevin R. Vincent. (2004) Clinical physiology and pharmacology conference: A nonpharmacological, evidence based medical approach using exercise method to lower and maintain blood pressure control in the elderly. International Urology and Nephrology 36:3, 473-476
    CrossRef

  36. 36

    Antonio Alberto Lopes, Sherman A. James, Friedrich K. Port, Akinlolu O. Ojo, Lawrence Y. Agodoa, Kenneth A. Jamerson. (2003) Meeting the Challenge to Improve the Treatment of Hypertension in Blacks. The Journal of Clinical Hypertension 5:6, 393-401
    CrossRef

  37. 37

    Kouichi Sakata, Yasushi Suwazono, Hideto Harada, Yasushi Okubo, Etsuko Kobayashi, Koji Nogawa. (2003) The Relationship Between Shift Work and the Onset of Hypertension in Male Japanese Workers. Journal of Occupational and Environmental Medicine 45:9, 1002-1006
    CrossRef

  38. 38

    Demosthenes B Panagiotakos, Christos H Pitsavos, Christina Chrysohoou, John Skoumas, Lambros Papadimitriou, Christodoulos Stefanadis, Pavlos K Toutouzas. (2003) Status and management of hypertension in Greece. Journal of Hypertension 21:8, 1483-1489
    CrossRef

  39. 39

    H.C Ulutin, D Ash, D Dodwell. (2003) Brachytherapy Boost to the Tumour Bed in High Risk Patients After Limited Surgery for Breast Cancer. Clinical Oncology 15:3, 156-159
    CrossRef

  40. 40

    Christine Chrysohoou, Christos Pitsavos, Demosthenes B. Panagiotakos, Peter F. Kokkinos, Christodoulos Stefanadis, Pavlos Toutouzas. (2003) The Association Between Physical Activity and the Development of Acute Coronary Syndromes in Treated and Untreated Hypertensive Subjects. The Journal of Clinical Hypertension 5:2, 115-120
    CrossRef

  41. 41

    Dawn K. Wilson, Ronald Friend, Nicole Teasley, Sabra Green, Irvine Lee Reaves, Domenic A. Sica. (2002) Motivational versus social cognitive interventions for promoting fruit and vegetable intake and physical activity in African American Adolescents. Annals of Behavioral Medicine 24:4, 310-319
    CrossRef

  42. 42

    Peter F. Kokkinos, Pittaras E. Andreas, Emmanuel Coutoulakis, John A. Colleran, Puneet Narayan, Charles O. Dotson, Wassim Choucair, Colleen Farmer, Bo Fernhall. (2002) Determinants of Exercise Blood Pressure Response in Normotensive and Hypertensive Women: Role of Cardiorespiratory Fitness. Journal of Cardiopulmonary Rehabilitation 22:3, 178-183
    CrossRef

  43. 43

    Carlos J. Rodriguez, Ralph L. Sacco, Robert R. Sciacca, Bernadette Boden-Albala, Shunichi Homma, Marco R. Di Tullio. (2002) Physical activity attenuates the effect of increased left ventricular mass on the risk of ischemic stroke. Journal of the American College of Cardiology 39:9, 1482-1488
    CrossRef

  44. 44

    David R Bassett, Eugene C Fitzhugh, Carlos J Crespo, George A King, James E McLaughlin. (2002) Physical Activity and Ethnic Differences in Hypertension Prevalence in the United States. Preventive Medicine 34:2, 179-186
    CrossRef

  45. 45

    Manu V. Chakravarthy, Michael J. Joyner, Frank W. Booth. (2002) An Obligation for Primary Care Physicians to Prescribe Physical Activity to Sedentary Patients to Reduce the Risk of Chronic Health Conditions. Mayo Clinic Proceedings 77:2, 165-173
    CrossRef

  46. 46

    M. V. Chakravarthy, M. J. Joyner, F. W. Booth. (2002) An Obligation for Primary Care Physicians to Prescribe Physical Activity to Sedentary Patients to Reduce the Risk of Chronic Health Conditions. Mayo Clinic Proceedings 77:2, 165-173
    CrossRef

  47. 47

    Yumiko Yokoyama, Takashi Kawamura, Akiko Tamakoshi, Akiko Noda, Makoto Hirai, Hidehiko Saito, Yoshiyuki Ohno. (2002) Comparison of Accelerometry and Oxymetry for Measuring Daily Physical Activity. Circulation Journal 66:8, 751-751
    CrossRef

  48. 48

    James A. Blumenthal, Andrew Sherwood, Elizabeth C. D. Gullette, Anastasia Georgiades, Damon Tweedy. (2002) Biobehavioral approaches to the treatment of essential hypertension.. Journal of Consulting and Clinical Psychology 70:3, 569-589
    CrossRef

  49. 49

    William J. Elliott, Henry R. Black. (2002) Treatment of Hypertension in the Elderly. The American Journal of Geriatric Cardiology 11:1, 11-22
    CrossRef

  50. 50

    Reena Karani, Mary Ann McLaughlin, Christine K. Cassel. (2001) Exercise in the Healthy Older Adult. The American Journal of Geriatric Cardiology 10:5, 269-273
    CrossRef

  51. 51

    Neil J. Stone. (2001) The optimal dietary strategy to manage risk associated with various dyslipidemias. Current Cardiology Reports 3:5, 391-400
    CrossRef

  52. 52

    Philip A. Ades, Gary J. Balady, Kathy Berra. (2001) Transforming Exercise-based Cardiac Rehabilitation Programs Into Secondary Prevention Centers: A National Imperative. Journal of Cardiopulmonary Rehabilitation 21:5, 263-272
    CrossRef

  53. 53

    Ali A. Ehsani. (2001) Exercise in Patients With Hypertension. The American Journal of Geriatric Cardiology 10:5, 253-260
    CrossRef

  54. 54

    ROBERT H. FAGARD. (2001) Exercise characteristics and the blood pressure response to dynamic physical training. Medicine and Science in Sports and Exercise 33:Supplement, S484-S492
    CrossRef

  55. 55

    S. E. Gariballa. (2000) Nutritional factors in stroke. British Journal of Nutrition 84:01, 5
    CrossRef

  56. 56

    M. J. Turner, R. J. Spina, W. M. Kohrt, A. A. Ehsani. (2000) Effect of Endurance Exercise Training on Left Ventricular Size and Remodeling in Older Adults With Hypertension. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 55:4, M245-M251
    CrossRef

  57. 57

    Peter F. Kokkinos, Vasilios Papademetriou. (2000) Exercise and hypertension. Coronary Artery Disease 11:2, 99-102
    CrossRef

  58. 58

    Bernadette Boden-Albala, Ralph L. Sacco. (2000) Lifestyle factors and stroke risk: Exercise, alcohol, diet, obesity, smoking, drug use, and stress. Current Atherosclerosis Reports 2:2, 160-166
    CrossRef

  59. 59

    Lynn M. Baxendale-Cox. (2000) An Overview of Essential Hypertension in Americans as a Multifactorial Phenomenon: Interaction of Biologic and Environmental Factors. Progress in Cardiovascular Nursing 15:2, 43-49
    CrossRef

  60. 60

    James M. Hagberg, Jung-Jun Park, Michael D. Brown. (2000) The Role of Exercise Training in the Treatment of Hypertension. Sports Medicine 30:3, 193-206
    CrossRef

  61. 61

    Sumino Hiroyuki, Nakamura Tetsuya, Kanda Tsugiyasu, Sakamaki Tetsuo, Sato Kunio, Saito Yuichiro, Hoshino Jin, Kurashina Toshiaki, Ono Zenpei, Takahashi Takashi, Ichikawa Shuichi, Kurabayashi Masahiko, Nagai Ryozo. (2000) Effects of Antihypertensive Therapy on Blood Pressure and Left Ventricular Hypertrophy in Patients with Severe Hypertension.. Japanese Heart Journal 41:3, 339-348
    CrossRef

  62. 62

    Ravinder K. Wali, Matthew R. Weir. (1999) Hypertensive cardiovascular disease in African Americans. Current Hypertension Reports 1:6, 521-528
    CrossRef

  63. 63

    ROBERT H. FAGARD. (1999) Physical activity in the prevention and treatment of hypertension in the obese. Medicine & Science in Sports & Exercise 31:Supplement 1, S624
    CrossRef

  64. 64

    Wilson D. Moreira, Flávio D. Fuchs, Jorge P. Ribeiro, Lawrence J. Appel. (1999) The Effects of Two Aerobic Training Intensities on Ambulatory Blood Pressure in Hypertensive Patients. Journal of Clinical Epidemiology 52:7, 637-642
    CrossRef

  65. 65

    Bernard M. Y. Cheung, Chu-Pak Lau. (1999) Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial. British Journal of Clinical Pharmacology 47:2, 179-187
    CrossRef

  66. 66

    PINI ORBACH, DAVID T. LOWENTHAL. (1998) Evaluation and treatment of hypertension in active individuals. Medicine & Science in Sports & Exercise 30:Supplement, S354-S366
    CrossRef

  67. 67

    Steven J. DiBiase, Lydia T. Komarnicky, Gordon F. Schwartz, Yang Xie, Carl M. Mansfield. (1998) The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82:11, 2212-2220
    CrossRef

  68. 68

    Efrain Reisin. (1997) NONPHARMACOLOGIC APPROACHES TO HYPERTENSION. Medical Clinics of North America 81:6, 1289-1303
    CrossRef

  69. 69

    Todd D. Miller, Gary J. Balady, Gerald F. Fletcher. (1997) Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Annals of Behavioral Medicine 19:3, 220-229
    CrossRef

  70. 70

    James W Leitch, Ross P Newling, Magdy Basta, Kerry Inder, Keith Dear, Peter J Fletcher. (1997) Randomized Trial of a Hospital-Based Exercise Training Program After Acute Myocardial Infarction: Cardiac Autonomic Effects. Journal of the American College of Cardiology 29:6, 1263-1268
    CrossRef

  71. 71

    Mahboob Rahman, Janice G. Douglas, Jackson T. Wright. (1997) PATHOPHYSIOLOGY AND TREATMENT IMPLICATIONS OF HYPERTENSION IN THE AFRICAN-AMERICAN POPULATION. Endocrinology & Metabolism Clinics of North America 26:1, 125-144
    CrossRef